Pacer Advisors’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-800
Closed -$21.1K 2594
2024
Q2
$21.1K Sell
800
-543
-40% -$14.3K ﹤0.01% 3398
2024
Q1
$43.4K Buy
+1,343
New +$43.4K ﹤0.01% 3228
2021
Q2
Sell
-4,594
Closed -$74K 1473
2021
Q1
$74K Buy
4,594
+2,184
+91% +$35.2K ﹤0.01% 1350
2020
Q4
$111K Buy
+2,410
New +$111K ﹤0.01% 1350